NO20091267L - Sammensetninger og fremgangsmåter for å forebygge kreft med cupredoxiner - Google Patents

Sammensetninger og fremgangsmåter for å forebygge kreft med cupredoxiner

Info

Publication number
NO20091267L
NO20091267L NO20091267A NO20091267A NO20091267L NO 20091267 L NO20091267 L NO 20091267L NO 20091267 A NO20091267 A NO 20091267A NO 20091267 A NO20091267 A NO 20091267A NO 20091267 L NO20091267 L NO 20091267L
Authority
NO
Norway
Prior art keywords
cupredoxins
compositions
methods
prevent cancer
cancer
Prior art date
Application number
NO20091267A
Other languages
English (en)
Norwegian (no)
Inventor
Ananda Chakrabarty
Tapas Das Gupta
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of NO20091267L publication Critical patent/NO20091267L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20091267A 2006-09-14 2009-03-26 Sammensetninger og fremgangsmåter for å forebygge kreft med cupredoxiner NO20091267L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
PCT/US2007/078371 WO2008033987A2 (en) 2006-09-14 2007-09-13 Compositions and methods to prevent cancer with cupredoxins

Publications (1)

Publication Number Publication Date
NO20091267L true NO20091267L (no) 2009-06-04

Family

ID=39184582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091267A NO20091267L (no) 2006-09-14 2009-03-26 Sammensetninger og fremgangsmåter for å forebygge kreft med cupredoxiner

Country Status (13)

Country Link
EP (1) EP2061498A4 (OSRAM)
JP (2) JP2010503409A (OSRAM)
KR (1) KR20090059152A (OSRAM)
CN (1) CN101595124A (OSRAM)
AU (1) AU2007296429A1 (OSRAM)
BR (1) BRPI0714987A2 (OSRAM)
CA (1) CA2663498A1 (OSRAM)
IL (1) IL197602A0 (OSRAM)
MX (1) MX2009002787A (OSRAM)
NO (1) NO20091267L (OSRAM)
RU (1) RU2009113812A (OSRAM)
SG (1) SG174784A1 (OSRAM)
WO (1) WO2008033987A2 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
US9598470B2 (en) * 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
AP2007003959A0 (en) 2004-10-07 2007-04-30 Ananda Chakrabarty Cupredoxin derived transport agents and methods ofuse thereof
AU2006269879A1 (en) 2005-07-19 2007-01-25 The Board Of Trustees Of The University Of Illinois Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
JP2010511408A (ja) 2006-12-04 2010-04-15 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 癌をＣｐＧリッチＤＮＡおよびキュプレドキシンで治療するための組成物および方法
WO2008098216A2 (en) * 2007-02-08 2008-08-14 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
US12331360B2 (en) 2017-09-29 2025-06-17 Oncgnostics Gmbh Risk determination for neoplasia and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
CN1506375A (zh) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物
AP2007003959A0 (en) * 2004-10-07 2007-04-30 Ananda Chakrabarty Cupredoxin derived transport agents and methods ofuse thereof
KR20080040631A (ko) * 2005-05-20 2008-05-08 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 에프린 신호전달과 관련된 질환을 쿠프레독신으로 치료하기위한 조성물과 방법
JP2009502797A (ja) * 2005-07-19 2009-01-29 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 血管形成をキュプレドキシンで制御するための組成物および方法

Also Published As

Publication number Publication date
IL197602A0 (en) 2011-08-01
CA2663498A1 (en) 2008-03-20
AU2007296429A1 (en) 2008-03-20
JP2010503409A (ja) 2010-02-04
JP2014050390A (ja) 2014-03-20
RU2009113812A (ru) 2010-10-20
MX2009002787A (es) 2009-08-27
WO2008033987A2 (en) 2008-03-20
SG174784A1 (en) 2011-10-28
WO2008033987A3 (en) 2009-04-30
KR20090059152A (ko) 2009-06-10
CN101595124A (zh) 2009-12-02
EP2061498A4 (en) 2009-11-04
EP2061498A2 (en) 2009-05-27
BRPI0714987A2 (pt) 2013-07-30

Similar Documents

Publication Publication Date Title
NO20091267L (no) Sammensetninger og fremgangsmåter for å forebygge kreft med cupredoxiner
NO20200775A1 (no) Fremgangsmåter og sammensetninger for behandling av kreft
CR10667A (es) Compositions and methods for diagnosing and treating cancer
DK2063907T3 (da) Fremgangsmåder og sammensætninger baseret på difteritoksin-interleukin-3-konjugater
BRPI0716325A2 (pt) Composição antimicrobianas
SMAP200900058A (it) Composti e composizioni come inibitori di proteinachinasi
SM201000108B (it) Composti e composizioni come inibitori di proteinachinasi
SMAP200900031A (it) Composti e composizioni come inibitori di proteinachinasi
EP2041267A4 (en) COMPOSITIONS AND METHODS FOR INCREASING THE USE OF GLYCEROL
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK1984009T3 (da) Farmaceutiske sammensætninger med forbedret stabilitet
DK3263589T5 (da) Peptidsekvenser og sammensætninger
EP2043136A4 (en) FILMING COMPOSITION
DK2373293T3 (da) Sammensætninger med reduceret dimerdannelse
ZA200905508B (en) Compositions and methods to prevent cancer with cupredoxins
DK3363857T3 (da) Hybride modstandsreducerende sammensætninger med højt polymerindhold
BRPI0905715A2 (pt) Composição farmacêutica e kit de componentes
NO20081287A (no) Brenselsammensetning og fremgangsmåte for å fremstille denne
FR2899479B1 (fr) Composition cicatrisante
BRPI0716458A2 (pt) Composição de vulcanizado
EP2227249A4 (en) IMPROVED IMMUNIZATION COMPOSITION
PL2187967T3 (pl) Sposoby i kompozycje do leczenia raka
BRPI0812932A2 (pt) Composições e métodos de tratar câncer
DK2152699T3 (da) Quinolon-forbindelse og farmaceutisk sammensætning
DK2334596T3 (da) Ferriphosphatbaseret sammensætning og anvendelse heraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application